Pacemaker Explantation in Patients With Lyme Carditis
Rachel Wamboldt1, Chang Nancy Wang2, Jennifer C Miller3
1Division of Cardiology, Kingston Health Science Center, Queen's University, Kingston, Ontario, Canada.
JACC. Case Reports
|May 26, 2022
Summary
Early recognition of Lyme carditis can prevent unnecessary pacemaker implantation. Device extraction may be an option for patients who recover normal heart conduction after antibiotic treatment for this tick-borne illness.
Area of Science:
- Cardiology
- Infectious Diseases
- Tick-Borne Illnesses
Background:
- Lyme carditis, a cardiac manifestation of Lyme disease, can cause significant conduction abnormalities.
- Early diagnosis and management are crucial to avoid invasive procedures.
Observation:
- Patients with Lyme carditis may develop atrioventricular conduction blocks.
- Pacemaker implantation is sometimes performed for these conduction abnormalities.
Findings:
- Prompt identification of Lyme carditis is key to preventing unnecessary pacemaker implantation.
- Device extraction should be considered post-antibiotic therapy in patients with recovered atrioventricular node conduction.
Implications:
- Optimizing Lyme carditis recognition can reduce healthcare costs and patient morbidity.
- This approach highlights the importance of monitoring cardiac function in Lyme disease patients.
Keywords:
AV blockAV, atrioventricularIDSA, International Diseases Society of AmericaIV, intravenousLC, Lyme carditisLyme carditisLyme diseasePPM, permanent pacemakerSILC, Suspicious Index in Lyme CarditispacemakerMore Related Videos
08:56Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
2.8K
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
3.6K
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
44
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
44
01:14Myocarditis III: Medical Management
24
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
24
01:18Endocarditis III: Medical Management
28
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
28
01:17Pericarditis III: Medical Management
33
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
33
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
71
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
71
01:22Pericarditis I: Introduction
27
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
27